Publication | Closed Access

A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms

VaccinationVeterinary VaccineVaccine DevelopmentPathogenesisPathologyVirologyPorcine DiseaseSwine VirusChimeric VaccineMedicineAnimal VirusVirological Outcomes